Skip to content
Hi-Doctor
Weight loss

How to Get Rybelsus Online in Croatia: A Comprehensive Guide

Looking for Rybelsus in Croatia? While Rybelsus is not prescribed for weight loss, you can get other effective, EU-approved weight-loss medications online. An EU-licensed doctor reviews your case for just €25.

11 April 2026
How to Get Rybelsus Online in Croatia: A Comprehensive Guide —

DIRECT ANSWER

An online consultation lets an EU-licensed doctor review your case and, if appropriate, issue a prescription that is valid across the EU.

Less than 4 hours on average

Prescription issued in less than 4 hours on average if approved.

EU-licensed doctors

Every case is reviewed by a licensed clinician.

Valid across the EU

Approved prescriptions can be used at any EU pharmacy.

In this article

Searching for Rybelsus online in Croatia? Many patients are looking for effective medication to manage their weight. While Rybelsus (oral semaglutide) is indicated for Type 2 Diabetes, and not specifically for weight loss in the EU, you can still get other EU-approved weight-management medications through an EU-licensed doctor. Hi-Doctor offers a straightforward, secure way to get a prescription online. Your case is reviewed by an EU-licensed doctor for a flat €25. If approved, you receive a prescription in under 24 hours, valid at any EU pharmacy. No risk — if the doctor says no, you get your money back.

How it works — get your weight-loss medication prescription in 4 steps

  1. Fill the online medical questionnaire (2–3 minutes) and pay the €25 consultation fee. This provides the doctor with essential information about your health and medical history.
  2. A licensed EU doctor reviews your case in private. Our doctors assess your information carefully. If the doctor determines the treatment is NOT appropriate for you, your €25 is refunded automatically — no risk.
  3. If approved, you receive a REMPE electronic prescription (PDF file) in your Hi-Doctor account and by email within 24 hours. This is Spain's official digital private prescription standard, recognised throughout the EU.
  4. Print the PDF or show it on your phone — present it at any pharmacy in the EU to collect the medication. Your REMPE prescription is valid at ANY pharmacy in the EU (Spain, Portugal, Italy, France, Germany, Netherlands, Belgium, Austria, Ireland, etc.) under cross-border prescription directive 2011/24/EU.

Who qualifies for weight-loss medication

Our EU-licensed doctors review each case individually to ensure patient safety and treatment appropriateness. Generally, they look for:

  • Adults (18+ years old) with a Body Mass Index (BMI) of 30 or higher (obesity).
  • Adults with a BMI of 27 or higher (overweight) who also have at least one weight-related comorbidity such as high blood pressure, type 2 diabetes, or high cholesterol.
  • No contraindications such as a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or severe gastrointestinal disease.
  • A commitment to lifestyle changes alongside medication, including diet and exercise.

The doctor will assess your full medical history and current health status to determine if a GLP-1 medication like semaglutide or tirzepatide is safe and suitable for you.

What weight-loss medication actually does (and doesn't do)

GLP-1 receptor agonists, such as semaglutide (found in Ozempic, Wegovy) and tirzepatide (Mounjaro), work by mimicking a natural hormone that targets areas of the brain involved in appetite regulation. This leads to:

  • Reduced appetite: You feel fuller, faster, and for longer, leading to fewer cravings and smaller portion sizes.
  • Slowed gastric emptying: Food stays in your stomach longer, contributing to prolonged feelings of fullness.
  • Improved blood sugar control: For those with Type 2 Diabetes, these medications help regulate blood glucose levels.

These medications are powerful tools for weight management but are not a magic bullet. They are most effective when combined with a healthy diet and regular physical activity. Weight loss is gradual and sustainable, typically over several months, not weeks. They do not eliminate the need for healthy habits.

Side effects and when to stop

Like all medications, GLP-1 agonists can have side effects. Most are mild and temporary, especially when starting treatment or increasing dosage. Common side effects include:

  • Nausea
  • Vomiting
  • Diarrhea or constipation
  • Abdominal pain
  • Headache

These usually subside as your body adjusts. It's crucial to follow your doctor's instructions carefully regarding dosage and administration. You should contact your doctor immediately if you experience:

  • Severe abdominal pain (which could indicate pancreatitis)
  • Persistent vomiting or diarrhea leading to dehydration
  • Signs of an allergic reaction (swelling of face, lips, tongue, or throat, difficulty breathing)
  • Vision changes (especially if you have diabetic retinopathy)

Your Hi-Doctor account includes a private, RGPD-compliant, auditable chat where you can communicate with your prescribing doctor about any concerns.

Why Hi-Doctor vs. walking into a clinic

Choosing Hi-Doctor for your weight-loss medication offers significant advantages:

  • Speed: Get your prescription in under 24 hours, compared to weeks or months for an in-person appointment.
  • Price: A flat €25 online consultation fee, fully refunded if treatment isn't appropriate, versus variable and often higher private clinic fees.
  • Privacy: Everything happens securely within your app and account. No waiting rooms, no reception desks, complete discretion.
  • Convenience: Consult from anywhere, anytime, using your phone or computer. No travel, no time off work.
  • Expertise & Trust: Over 50,000 patients served with a 4.8 Trustpilot rating. Our EU-licensed doctors review every case individually, ensuring safe and appropriate care.

COMMON QUESTIONS

Frequently asked questions

If the EU-licensed doctor determines that the treatment is not appropriate for your case, your €25 consultation fee is refunded automatically. You pay nothing if the treatment isn't approved.

Licensed EU doctors
Doctor review in less than 2 hours on average
50,000+ patients served
Secure patient account
Online Doctor Legitimacy and EU Regulations Explained — article cover image

Online Doctor Legitimacy and EU Regulations Explained

This article clarifies the legitimacy of online doctor services within the European Union, detailing the regulations that ensure patient safety and the validity of cross-border prescriptions.

14 August 2026
Understanding REMPE Electronic Prescriptions: A Guide for EU Patients — article cover image

Understanding REMPE Electronic Prescriptions: A Guide for EU Patients

This guide explains the Spanish REMPE electronic prescription system, its function within Spain, and its recognition across the EU. It clarifies how these prescriptions are reviewed and processed by pharmacists, both.

13 August 2026
Zavamed Alternatives: 8 Options Compared (2026) — article cover image

Zavamed Alternatives: 8 Options Compared (2026)

Looking for Zavamed alternatives in 2026? We compare 8 online health services by market, treatment coverage and supported consultation or fulfilment model.

6 August 2026
Dokteronline Alternatives: 8 Options Compared (2026) — article cover image

Dokteronline Alternatives: 8 Options Compared (2026)

Looking for Dokteronline alternatives? We compare 8 online healthcare services across the EU, UK and US, with clear market labels and service-model differences.

6 August 2026
Best Telehealth Men's Health Services in Spain (2026) — article cover image

Best Telehealth Men's Health Services in Spain (2026)

We compare seven telehealth men's health services available in Spain in 2026, from EU e-prescription platforms to doctor-directory and generalist services covering sexual health, hair growth and weight management.

6 August 2026
Best Online ED Treatment Providers in Europe (2026) — article cover image

Best Online ED Treatment Providers in Europe (2026)

Compare the top online ED treatment providers in Europe for 2026. We evaluate services by their consultation model, market availability, and approach to sexual healthcare.

6 August 2026

HI-DOCTOR NEWSLETTER

We'll tell you when we add new treatments.

At most 2 emails a month. No spam. Updates on online health, EU telemedicine, and clinical guides signed by licensed doctors.